NCT00665834 - Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

DyslipidemiaAcute Coronary Syndromes

Interventions

DRUG

rosuvastatin

rosuvastatin 20 mg from day 0 to (maximum) day 6

DRUG

placebo

placebo 20 mg from day 0 to (maximum) day 6

DRUG

rosuvastatin

rosuvastatin 20 mg from discharge until the end of the study

DRUG

atorvastatin

atorvastatin 80 mg from discharge until the end of the study

Trial Locations (2)

Kingston General Hospital, Kingston

Vascular Disease Prevention and Research Centre, Hotel Dieu Hospital, Kingston